Watch Demo

Israel Anti-Infective Industry Outlook 2024 - 2028

See how Israel Anti-Infective performed compared to key markets.

Key Market Indicators

Israeli antibiotics imports are projected to decline significantly, with estimates showing a decrease from $14.3 million in 2023 to just over $5 million by 2028. This represents an average annual reduction of 16.5%. The trend is consistent with a longer-term decline, as the country's demand for antibiotics has fallen by an average of 6.3% each year since 2000. On the export front, Israel's antibiotics industry has also experienced a downturn. In 2023, the nation exported approximately $2.8 million worth of antibiotics, a sharp decline from the $3.6 million recorded in 2022. This 22.4% drop from the previous year underscores a broader trend, with Israeli antibiotic exports decreasing by an average of 12% annually since 2000.

Marketing Banner

Israel Anti-Infective Market Data and Forecasts

How much will Israel Anti-Infective Market grow to 2028?

Forecast: Import of Antibiotics to Israel
Forecast: Import of Tetracyclines to Israel
Forecast: Import of Penicillins to Israel
Forecast: Export of Tetracyclines from Israel
Forecast: Import of Benzyl Alcohol to Israel
More in Anti-Infective Industry for 2028